CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471144582
- Phone
- 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,050,832
- in 7 filings, $404K under 10b5-1 plans
Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-10 | TZIANABOS ARTHUR Interim Executive Chair | Sale 10b5-1 | −4,355 | $40.00 | $174K | 31,339 |
| 2026-03-10 | TZIANABOS ARTHUR Interim Executive Chair | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,955 | 118,696 | ||
| 2026-03-02 | Krainer Adrian R. Director | Sale 10b5-1 | −7,229 | $39.66 | $287K | 316,545 |
| 2026-02-17 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Grant or award · Employee Stock Option (Right to Buy) | +53,000 | 53,000 | ||
| 2026-02-17 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Grant or award · Restricted Stock Units | +35,000 | 35,000 | ||
| 2026-02-17 | Ticho Barry CHIEF MEDICAL OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2026-02-17 | Ticho Barry CHIEF MEDICAL OFFICER | Grant or award · Restricted Stock Units | +40,000 | 40,000 | ||
| 2026-02-17 | Leggett Thomas Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2026-02-17 | Leggett Thomas Chief Financial Officer | Grant or award · Restricted Stock Units | +40,000 | 40,000 | ||
| 2026-02-17 | Hoitt Jason Chief Patient Officer | Grant or award · Employee Stock Option (Right to Buy) | +72,000 | 72,000 | ||
| 2026-02-17 | Hoitt Jason Chief Patient Officer | Grant or award · Restricted Stock Units | +48,000 | 48,000 | ||
| 2026-02-17 | SMITH IAN F Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +193,000 | 193,000 | ||
| 2026-02-17 | SMITH IAN F Chief Executive Officer | Grant or award · Restricted Stock Units | +129,000 | 129,000 | ||
| 2025-12-31 | LEVIN ARTHUR A Director | Option exercise | +1,211 | 4,842 | ||
| 2025-12-31 | LEVIN ARTHUR A Director | Option exercise · Restricted Stock Units | −1,211 | 0 | ||
| 2025-12-08 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale 10b5-1 | −1,300 | $31.60 | $41K | 14,509 |
| 2025-12-08 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale 10b5-1 | −2,678 | $32.61 | $87K | 11,831 |
| 2025-12-08 | Kaye Edward M. MD Director | Sale 10b5-1 | −3,825 | $31.44 | $120K | 58,729 |
| 2025-12-08 | Kaye Edward M. MD Director | Sale 10b5-1 | −8,274 | $32.52 | $269K | 50,455 |
| 2025-12-08 | Kaye Edward M. MD Director | Sale 10b5-1 | −1,331 | $33.10 | $44K | 49,124 |
Page 6 of 13 · 256 trades